ESR1 and prostate carcinoma: Consequently, we performed IHC with DAB for ERa with similar conditions to the ones used for ColNu mIHCF (overnight incubation of the Ready-to-Use IVD antibody) in all the prostate cancer samples from TMA-0, TMA-I and TMA-II arrays (globally, nine cases of prostate cancer).